Company Overview of DBV Technologies S.A.
Paul-Henri Lambert M.D.
Member of the Scientific Advisory Board, DBV Technologies S.A.
|Age||Total Calculated Compensation||This person is connected to 2 Board Members in 2 different organizations across 2 different industries.|
See Board Relationships
177-181 avenue Pierre BrossolettePhone: 33 1 55 42 78 78
Montrouge, Ile-de-France 92120
Board Members MembershipsThere is no Board Members Memberships data available.
Université de Liège
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Carlos V. Paya M.D., Ph.D.||Chief Executive Officer, President and Director|
Immune Design Corp.
|Werner Cautreels Ph.D.||Chairman, Chief Executive Officer and President|
Selecta Biosciences, Inc.
|Stephen George Dilly M.B.B.S, Ph.D.||Chief Executive Officer, President and Director|
Aimmune Therapeutics, Inc.
|$372.9K||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.